<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35955979</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>15</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>27</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4363</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm11154363</ELocationID><Abstract><AbstractText>Background. The profile of cellular immunological responses of children across the spectrum of COVID-19, ranging from acute SARS-CoV-2 infection to full recovery or Long COVID, has not yet been fully investigated. Methods. We examined and compared cytokines in sera and cell subsets in peripheral blood mononuclear cells (B and regulatory T lymphocytes) collected from four distinct groups of children, distributed as follows: younger than 18 years of age with either acute SARS-CoV-2 infection (n = 49); fully recovered from COVID-19 (n = 32); with persistent symptoms (Long COVID, n = 51); and healthy controls (n = 9). Results. In the later stages after SARS-CoV-2 infection, the cohorts of children, both with recovered and persistent symptoms, showed skewed T and B subsets, with remarkable differences when compared with children at the onset of the infection and with controls. The frequencies of IgD+CD27&#x2212; na&#xef;ve B cells, IgD+IgM+ and CD27&#x2212;IgM+CD38dim B cells were higher in children with recent infection than in those with an older history of disease (p &lt; 0.0001 for all); similarly, the total and natural Tregs compartments were more represented in children at onset when compared with Long COVID (p &lt; 0.0001 and p = 0.0005, respectively). Despite the heterogeneity, partially due to age, sex and infection incidence, the susceptibility of certain children to develop persistent symptoms after infection appeared to be associated with the imbalance of the adaptive immune response. Following up and comparing recovered versus Long COVID patients, we analyzed the role of circulating na&#xef;ve and switched B and regulatory T lymphocytes in counteracting the evolution of the symptomatology emerged, finding an interesting correlation between the amount and ability to reconstitute the natural Tregs component with the persistence of symptoms (linear regression, p = 0.0026). Conclusions. In this study, we suggest that children affected by Long COVID may have a compromised ability to switch from the innate to the adaptive immune response, as supported by our data showing a contraction of na&#xef;ve and switched B cell compartment and an unstable balance of regulatory T lymphocytes occurring in these children. However, further prospective immunological studies are needed to better clarify which factors (epigenetic, diet, environment, etc.) are involved in the impairment of the immunological mechanisms in the Long COVID patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8567-2639</Identifier><AffiliationInfo><Affiliation>Department of Laboratory and Infectivology Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Piero</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6095-9510</Identifier><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Rose</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5394-8335</Identifier><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tredicine</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Translazional Medicine and Surgery, Section of General Pathology, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereyra Boza</LastName><ForeName>Maria Del Carmen</ForeName><Initials>MDC</Initials><AffiliationInfo><Affiliation>Department of Biotecnologial, Basic, Intensivological and Perioperatory Sciences-Section of Microbiology, Universit&#xe0; Cattolica del S Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camponeschi</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1400-5366</Identifier><AffiliationInfo><Affiliation>Department of Translazional Medicine and Surgery, Section of General Pathology, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Chemical Sciences and Technologies ''Giulio Natta'' (SCITEC)-CNR, Largo Francesco Vito 1, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2372-084X</Identifier><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zampino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Anna E S</ForeName><Initials>AES</Initials><Identifier Source="ORCID">0000-0003-3551-6982</Identifier><AffiliationInfo><Affiliation>School of Biological Sciences, University of Auckland, Auckland 92019, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rende</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, Section of Human, Clinical and Forensic Anatomy, University of Perugia, 60132 Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ria</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Translazional Medicine and Surgery, Section of General Pathology, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biotecnologial, Basic, Intensivological and Perioperatory Sciences-Section of Microbiology, Universit&#xe0; Cattolica del S Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanguinetti</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9780-7059</Identifier><AffiliationInfo><Affiliation>Department of Laboratory and Infectivology Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biotecnologial, Basic, Intensivological and Perioperatory Sciences-Section of Microbiology, Universit&#xe0; Cattolica del S Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delogu</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biotecnologial, Basic, Intensivological and Perioperatory Sciences-Section of Microbiology, Universit&#xe0; Cattolica del S Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mater Olbia Hospital, 07026 Olbia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sali</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory and Infectivology Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biotecnologial, Basic, Intensivological and Perioperatory Sciences-Section of Microbiology, Universit&#xe0; Cattolica del S Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Sante</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Translazional Medicine and Surgery, Section of General Pathology, Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, Section of Human, Clinical and Forensic Anatomy, University of Perugia, 60132 Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>On Behalf Of The Gemelli-Pediatric Covid-Team</LastName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>65925795</GrantID><Agency>Pfizer (Italy)</Agency><Country/></Grant><Grant><GrantID>2021.0347</GrantID><Agency>Fondazione Cassa Risparmio Perugia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 immunopathology</Keyword><Keyword MajorTopicYN="N">T cells</Keyword><Keyword MajorTopicYN="N">childhood SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">pediatric Long COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35955979</ArticleId><ArticleId IdType="pmc">PMC9369242</ArticleId><ArticleId IdType="doi">10.3390/jcm11154363</ArticleId><ArticleId IdType="pii">jcm11154363</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Parri N., Lenge M., Cantoni B., Arrighini A., Romanengo M., Urbino A., Da Dalt L., Verdoni L., Giacchero R., Lanari M., et al. COVID-19 in 17 Italian Pediatric Emergency Departments. Pediatrics. 2020;146:e20201235. doi: 10.1542/peds.2020-1235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-1235</ArticleId><ArticleId IdType="pubmed">32968031</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;tzinger F., Santiago-Garc&#xed;a B., Noguera-Juli&#xe1;n A., Lanaspa M., Lancella L., Carducci F.I.C., Gabrovska N., Velizarova S., Prunk P., Osterman V., et al. COVID-19 in Children and Adolescents in Europe: A Multinational, Multicentre Cohort Study. Lancet Child Adolesc. Health. 2020;4:653&#x2013;661. doi: 10.1016/S2352-4642(20)30177-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30177-2</ArticleId><ArticleId IdType="pmc">PMC7316447</ArticleId><ArticleId IdType="pubmed">32593339</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC COVID-19 Response Team Severe Outcomes among Patients with Coronavirus Disease 2019 (COVID-19)-United States, 12 February&#x2013;16 March 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:343&#x2013;346. doi: 10.15585/mmwr.mm6912e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6912e2</ArticleId><ArticleId IdType="pmc">PMC7725513</ArticleId><ArticleId IdType="pubmed">32214079</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., Tong S. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145:e20200702. doi: 10.1542/peds.2020-0702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-0702</ArticleId><ArticleId IdType="pubmed">32179660</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., Newburger J.W., Kleinman L.C., Heidemann S.M., Martin A.A., et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N. Engl. J. Med. 2020;383:334&#x2013;346. doi: 10.1056/NEJMoa2021680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Onder G., Rezza G., Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020;323:1775&#x2013;1776. doi: 10.1001/jama.2020.4683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4683</ArticleId><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72,314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai K., Liu W., Liu C., Fu Y., Hu J., Qin Y., Zhang Q., Chen H., Xu F., Li C. Clinical Analysis of 25 COVID-19 Infections in Children. Pediatric Infect. Dis. J. 2020;39:e100&#x2013;e103. doi: 10.1097/INF.0000000000002740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002740</ArticleId><ArticleId IdType="pubmed">32520888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J., Zhang W., Wang Y., Bao S., Li Y., et al. SARS-CoV-2 Infection in Children. N. Engl. J. Med. 2020;382:1663&#x2013;1665. doi: 10.1056/NEJMc2005073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2005073</ArticleId><ArticleId IdType="pmc">PMC7121177</ArticleId><ArticleId IdType="pubmed">32187458</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentini P., Sodero G., Buonsenso D. The Relationship between COVID-19 and Innate Immunity in Children: A Review. Children. 2021;8:266. doi: 10.3390/children8040266.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children8040266</ArticleId><ArticleId IdType="pmc">PMC8066225</ArticleId><ArticleId IdType="pubmed">33808490</ArticleId></ArticleIdList></Reference><Reference><Citation>CMMID COVID-19 Working Group. Davies N.G., Klepac P., Liu Y., Prem K., Jit M., Eggo R.M. Age-Dependent Effects in the Transmission and Control of COVID-19 Epidemics. Nat. Med. 2020;26:1205&#x2013;1211. doi: 10.1038/s41591-020-0962-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0962-9</ArticleId><ArticleId IdType="pubmed">32546824</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt A.A., Dargham S.R., Loka S., Shaik R.M., Chemaitelly H., Tang P., Hasan M.R., Coyle P.V., Yassine H.M., Al-Khatib H.A., et al. Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant. Clin. Infect. Dis. 2022:ciac275. doi: 10.1093/cid/ciac275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac275</ArticleId><ArticleId IdType="pmc">PMC9047187</ArticleId><ArticleId IdType="pubmed">35404391</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients after Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Allin B., Nugawela M.D., Rojas N., Dalrymple E., Pereira S.P., Soni M., Knight M., Cheung E.Y., Heyman I., et al. Long COVID (Post-COVID-19 Condition) in Children: A Modified Delphi Process. Arch. Dis. Child. 2022;107:674&#x2013;680. doi: 10.1136/archdischild-2021-323624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Gennaro L.D., Rose C.D., Morello R., D&#x2019;Ilario F., Zampino G., Piazza M., Boner A.L., Iraci C., O&#x2019;Connell S., et al. Long-Term Outcomes of Pediatric Infections: From Traditional Infectious Diseases to Long Covid. Future Microbiol. 2022;17:551&#x2013;571. doi: 10.2217/fmb-2022-0031.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0031</ArticleId><ArticleId IdType="pmc">PMC8910780</ArticleId><ArticleId IdType="pubmed">35264003</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., Sinatti D., Ricchiuto A., Carfi A., Valentini P. Preliminary Evidence on Long COVID in Children. Acta Paediatr. 2021;110:2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Case Report and Systematic Review Suggest That Children May Experience Similar Long-term Effects to Adults after Clinical COVID-19. Acta Paediatr. 2021;110:914&#x2013;921. doi: 10.1111/apa.15673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15673</ArticleId><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., Gamirova A., Shikhaleva A., Andreeva M., Blyuss O., El-Taravi Y., DunnGalvin A., Comberiati P., et al. Risk Factors for Post-COVID-19 Condition in Previously Hospitalised Children Using the ISARIC Global Follow-up Protocol: A Prospective Cohort Study. Eur. Respir. J. 2022;59:2101341. doi: 10.1183/13993003.01341-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Pujol F.E., Munblit D., Pata D., McFarland S., Simpson F.K. Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: A survey of 510 children. Future Microbiol. 2022;17:577&#x2013;588. doi: 10.2217/fmb-2021-0285.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2021-0285</ArticleId><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Di Giuda D., Sigfrid L., Pizzuto D.A., Di Sante G., De Rose C., Lazzareschi I., Sali M., Baldi F., Chieffo D.P.R., et al. Evidence of Lung Perfusion Defects and Ongoing Inflammation in an Adolescent with Post-Acute Sequelae of SARS-CoV-2 Infection. Lancet Child Adolesc. Health. 2021;5:677&#x2013;680. doi: 10.1016/S2352-4642(21)00196-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00196-6</ArticleId><ArticleId IdType="pmc">PMC8324416</ArticleId><ArticleId IdType="pubmed">34339624</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Sante G., Buonsenso D., De Rose C., Tredicine M., Palucci I., De Maio F., Camponeschi C., Bonadia N., Biasucci D., Pata D., et al. Immunopathology of SARS-CoV-2 Infection: A Focus on T Regulatory and B Cell Responses in Children Compared with Adults. Children. 2022;9:681. doi: 10.3390/children9050681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9050681</ArticleId><ArticleId IdType="pmc">PMC9139466</ArticleId><ArticleId IdType="pubmed">35626859</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Di Sante G., Sali M. CURE COVID-19 Study Group Cytokine Profile in an Adolescent With Pediatric Multisystem Inflammatory Syndrome Temporally Related to COVID-19. Pediatr. Infect. Dis. J. 2020;39:e213&#x2013;e215. doi: 10.1097/INF.0000000000002802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002802</ArticleId><ArticleId IdType="pubmed">32677813</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. Clues to Long COVID. Science. 2022;376:1261&#x2013;1265. doi: 10.1126/science.add4297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.add4297</ArticleId><ArticleId IdType="pubmed">35709281</ArticleId></ArticleIdList></Reference><Reference><Citation>Diorio C., McNerney K.O., Lambert M., Paessler M., Anderson E.M., Henrickson S.E., Chase J., Liebling E.J., Burudpakdee C., Lee J.H., et al. Evidence of Thrombotic Microangiopathy in Children with SARS-CoV-2 across the Spectrum of Clinical Presentations. Blood Adv. 2020;4:6051&#x2013;6063. doi: 10.1182/bloodadvances.2020003471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003471</ArticleId><ArticleId IdType="pmc">PMC7724906</ArticleId><ArticleId IdType="pubmed">33290544</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P., Matthay M.A., Calfee C.S. Is a &#x201c;Cytokine Storm&#x201d; Relevant to COVID-19? JAMA Intern. Med. 2020;180:1152&#x2013;1154. doi: 10.1001/jamainternmed.2020.3313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.3313</ArticleId><ArticleId IdType="pubmed">32602883</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallapaty S. Kids and COVID: Why Young Immune Systems Are Still on Top. Nature. 2021;597:166&#x2013;168. doi: 10.1038/d41586-021-02423-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-02423-8</ArticleId><ArticleId IdType="pubmed">34493845</ArticleId></ArticleIdList></Reference><Reference><Citation>Moderbacher C.R., Ramirez S.I., Dan J.M., Grifoni A., Hastie K.M., Weiskopf D., Belanger S., Abbott R.K., Kim C., Choi J., et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. Cell. 2020;183:996&#x2013;1012. doi: 10.1016/j.cell.2020.09.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.038</ArticleId><ArticleId IdType="pmc">PMC7494270</ArticleId><ArticleId IdType="pubmed">33010815</ArticleId></ArticleIdList></Reference><Reference><Citation>Meckiff B.J., Ram&#xed;rez-Su&#xe1;stegui C., Fajardo V., Chee S.J., Kusnadi A., Simon H., Eschweiler S., Grifoni A., Pelosi E., Weiskopf D., et al. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19. Cell. 2020;183:1340&#x2013;1353.e16. doi: 10.1016/j.cell.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7534589</ArticleId><ArticleId IdType="pubmed">33096020</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni A., Tian Y., Sette A., Weiskopf D. Transcriptomic Immune Profiles of Human Flavivirus-specific T-cell Responses. Immunology. 2020;160:3&#x2013;9. doi: 10.1111/imm.13161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13161</ArticleId><ArticleId IdType="pmc">PMC7160650</ArticleId><ArticleId IdType="pubmed">31778581</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio C.R., Cotugno N., Sardh F., Pou C., Amodio D., Rodriguez L., Tan Z., Zicari S., Ruggiero A., Pascucci G.R., et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell. 2020;183:968&#x2013;981.e7. doi: 10.1016/j.cell.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Alivernini S., Tolusso B., Petricca L., Bui L., Di Sante G., Peluso G., Benvenuto R., Fedele A.L., Federico F., Ferraccioli G., et al. Synovial Features of Patients with Rheumatoid Arthritis and Psoriatic Arthritis in Clinical and Ultrasound Remission Differ under Anti-TNF Therapy: A Clue to Interpret Different Chances of Relapse after Clinical Remission? Ann. Rheum. Dis. 2017;76:1228&#x2013;1236. doi: 10.1136/annrheumdis-2016-210424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2016-210424</ArticleId><ArticleId IdType="pmc">PMC5530352</ArticleId><ArticleId IdType="pubmed">28119289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y., Zhou L., Xia Y., Wang W., Wang Y., Li L., Qi Z., Zhong L., Sun J., Tang W., et al. Reference Values for Peripheral Blood Lymphocyte Subsets of Healthy Children in China. J. Allergy Clin. Immunol. 2018;142:970&#x2013;973.e8. doi: 10.1016/j.jaci.2018.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.04.022</ArticleId><ArticleId IdType="pubmed">29746882</ArticleId></ArticleIdList></Reference><Reference><Citation>Schatorj&#xe9; E.J.H., Gemen E.F.A., Driessen G.J.A., Leuvenink J., van Hout R.W.N.M., de Vries E. Paediatric Reference Values for the Peripheral T Cell Compartment: T Lymphocyte Subsets in Children. Scand. J. Immunol. 2012;75:436&#x2013;444. doi: 10.1111/j.1365-3083.2012.02671.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2012.02671.x</ArticleId><ArticleId IdType="pubmed">22420532</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg S.P., Connors T.J., Zhu Y., Baldwin M.R., Lin W.-H., Wontakal S., Szabo P.A., Wells S.B., Dogra P., Gray J., et al. Distinct Antibody Responses to SARS-CoV-2 in Children and Adults across the COVID-19 Clinical Spectrum. Nat. Immunol. 2021;22:25&#x2013;31. doi: 10.1038/s41590-020-00826-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00826-9</ArticleId><ArticleId IdType="pmc">PMC8136619</ArticleId><ArticleId IdType="pubmed">33154590</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosif S., Neeland M.R., Sutton P., Licciardi P.V., Sarkar S., Selva K.J., Do L.A.H., Donato C., Toh Z.Q., Higgins R., et al. Immune Responses to SARS-CoV-2 in Three Children of Parents with Symptomatic COVID-19. Nat. Commun. 2020;11:5703. doi: 10.1038/s41467-020-19545-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19545-8</ArticleId><ArticleId IdType="pmc">PMC7658256</ArticleId><ArticleId IdType="pubmed">33177504</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen C.A., Li A.P.Y., Hachim A., Hui D.S.C., Kwan M.Y.W., Tsang O.T.Y., Chiu S.S., Chan W.H., Yau Y.S., Kavian N., et al. SARS-CoV-2 Specific T Cell Responses Are Lower in Children and Increase with Age and Time after Infection. Nat. Commun. 2021;12:4678. doi: 10.1038/s41467-021-24938-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24938-4</ArticleId><ArticleId IdType="pmc">PMC8322064</ArticleId><ArticleId IdType="pubmed">34326343</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartsch Y.C., Wang C., Zohar T., Fischinger S., Atyeo C., Burke J.S., Kang J., Edlow A.G., Fasano A., Baden L.R., et al. Humoral Signatures of Protective and Pathological SARS-CoV-2 Infection in Children. Nat. Med. 2021;27:454&#x2013;462. doi: 10.1038/s41591-021-01263-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01263-3</ArticleId><ArticleId IdType="pmc">PMC8315827</ArticleId><ArticleId IdType="pubmed">33589825</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo J., Dowell A.C., Pearce H., Verma K., Long H.M., Begum J., Aiano F., Amin-Chowdhury Z., Hoschler K., Brooks T., et al. Robust SARS-CoV-2-Specific T Cell Immunity Is Maintained at 6 Months Following Primary Infection. Nat. Immunol. 2021;22:620&#x2013;626. doi: 10.1038/s41590-021-00902-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00902-8</ArticleId><ArticleId IdType="pmc">PMC7610739</ArticleId><ArticleId IdType="pubmed">33674800</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The Immunology and Immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological Dysfunction Persists for 8 Months Following Initial Mild-to-Moderate SARS-CoV-2 Infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., Pazukhina E., Ricchiuto A., Sinatti D., Zona M., De Matteis A., D&#x2019;Ilario F., Gentili C., Lanni R., et al. Post-COVID Condition in Adults and Children Living in the Same Household in Italy: A Prospective Cohort Study Using the ISARIC Global Follow-Up Protocol. Front. Pediatr. 2022;10:834875. doi: 10.3389/fped.2022.834875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.834875</ArticleId><ArticleId IdType="pmc">PMC9070551</ArticleId><ArticleId IdType="pubmed">35529336</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Naughton A., Kiersey R., Holden D., Gardiner M., Dowds J., O&#x2019;Brien K., Bannan C., Nadarajan P., et al. Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health. Front. Immunol. 2021;12:676932. doi: 10.3389/fimmu.2021.676932.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.676932</ArticleId><ArticleId IdType="pmc">PMC8138306</ArticleId><ArticleId IdType="pubmed">34025675</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F.J., Hope C.M., Masavuli M.G., Lynn M.A., Mekonnen Z.A., Yeow A.E.L., Garcia-Valtanen P., Al-Delfi Z., Gummow J., Ferguson C., et al. Long-Term Perturbation of the Peripheral Immune System Months after SARS-CoV-2 Infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusnadi A., Ram&#xed;rez-Su&#xe1;stegui C., Fajardo V., Chee S.J., Meckiff B.J., Simon H., Pelosi E., Seumois G., Ay F., Vijayanand P., et al. Severely Ill Patients with COVID-19 Display Impaired Exhaustion Features in SARS-CoV-2&#x2013;Reactive CD8+ T Cells. Sci. Immunol. 2021;6:eabe4782. doi: 10.1126/sciimmunol.abe4782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abe4782</ArticleId><ArticleId IdType="pmc">PMC8101257</ArticleId><ArticleId IdType="pubmed">33478949</ArticleId></ArticleIdList></Reference><Reference><Citation>Files J.K., Boppana S., Perez M.D., Sarkar S., Lowman K.E., Qin K., Sterrett S., Carlin E., Bansal A., Sabbaj S., et al. Sustained Cellular Immune Dysregulation in Individuals Recovering from SARS-CoV-2 Infection. J. Clin. Investig. 2021;131:e140491. doi: 10.1172/JCI140491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140491</ArticleId><ArticleId IdType="pmc">PMC7773371</ArticleId><ArticleId IdType="pubmed">33119547</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu&#x161;nik J., Richter E., Schulte B., Dolscheid-Pommerich R., Bode C., Putensen C., Hartmann G., Alter G., Streeck H. Memory B Cells Targeting SARS-CoV-2 Spike Protein and Their Dependence on CD4+ T Cell Help. Cell Rep. 2021;35:109320. doi: 10.1016/j.celrep.2021.109320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109320</ArticleId><ArticleId IdType="pmc">PMC8192958</ArticleId><ArticleId IdType="pubmed">34146478</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa H.A., Shaw T.N., Knight S.B., Wemyss K., McClure F.A., Pearmain L., Prise I., Jagger C., Morgan D.J., Khan S., et al. Alterations in T and B Cell Function Persist in Convalescent COVID-19 Patients. Med. 2021;2:720&#x2013;735.e4. doi: 10.1016/j.medj.2021.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>Boothby I.C., Cohen J.N., Rosenblum M.D. Regulatory T Cells in Skin Injury: At the Crossroads of Tolerance and Tissue Repair. Sci. Immunol. 2020;5:eaaz9631. doi: 10.1126/sciimmunol.aaz9631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aaz9631</ArticleId><ArticleId IdType="pmc">PMC7274208</ArticleId><ArticleId IdType="pubmed">32358172</ArticleId></ArticleIdList></Reference><Reference><Citation>Linterman M.A., Pierson W., Lee S.K., Kallies A., Kawamoto S., Rayner T.F., Srivastava M., Divekar D.P., Beaton L., Hogan J.J., et al. Foxp3+ Follicular Regulatory T Cells Control the Germinal Center Response. Nat. Med. 2011;17:975&#x2013;982. doi: 10.1038/nm.2425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2425</ArticleId><ArticleId IdType="pmc">PMC3182542</ArticleId><ArticleId IdType="pubmed">21785433</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund J.M., Hsing L., Pham T.T., Rudensky A.Y. Coordination of Early Protective Immunity to Viral Infection by Regulatory T Cells. Science. 2008;320:1220&#x2013;1224. doi: 10.1126/science.1155209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1155209</ArticleId><ArticleId IdType="pmc">PMC2519146</ArticleId><ArticleId IdType="pubmed">18436744</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway S.R., Lazarski C.A., Field N.E., Jensen-Wachspress M., Lang H., Kankate V., Durkee-Shock J., Kinoshita H., Suslovic W., Webber K., et al. SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection. Front. Immunol. 2022;12:793197. doi: 10.3389/fimmu.2021.793197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.793197</ArticleId><ArticleId IdType="pmc">PMC8803660</ArticleId><ArticleId IdType="pubmed">35116027</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss P. The T Cell Immune Response against SARS-CoV-2. Nat. Immunol. 2022;23:186&#x2013;193. doi: 10.1038/s41590-021-01122-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01122-w</ArticleId><ArticleId IdType="pubmed">35105982</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudlay D., Kofiadi I., Khaitov M. Peculiarities of the T Cell Immune Response in COVID-19. Vaccines. 2022;10:242. doi: 10.3390/vaccines10020242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020242</ArticleId><ArticleId IdType="pmc">PMC8877307</ArticleId><ArticleId IdType="pubmed">35214700</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandolfi F., Cianci R., Casciano F., Pagliari D., De Pasquale T., Landolfi R., Di Sante G., Kurnick J.T., Ria F. Skewed T-Cell Receptor Repertoire: More than a Marker of Malignancy, a Tool to Dissect the Immunopathology of Inflammatory Diseases. J. Biol. Regul. Homeost. Agents. 2011;25:153&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">21880203</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker L.M., Gilboa T., Ogata A.F., Senussi Y., Lazarovits R., Boribong B.P., Bartsch Y.C., Loiselle M., Rivas M.N., Porritt R.A., et al. Multisystem Inflammatory Syndrome in Children Is Driven by Zonulin-Dependent Loss of Gut Mucosal Barrier. J. Clin. Investig. 2021;131:149633. doi: 10.1172/JCI149633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI149633</ArticleId><ArticleId IdType="pmc">PMC8279585</ArticleId><ArticleId IdType="pubmed">34032635</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pereira S.M.P., Shafran R., de Stavola B.L., Rojas N., McOwat K., Simmons R., Zavala M., O&#x2019;Mahoney L., Chalder T., et al. Physical and Mental Health 3 Months after SARS-CoV-2 Infection (Long COVID) among Adolescents in England (CLoCk): A National Matched Cohort Study. Lancet Child Adolesc. Health. 2022;6:230&#x2013;239. doi: 10.1016/S2352-4642(22)00022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Yang X., Wang H., Li Z., Deng H., Liu J., Xiong S., He J., Feng X., Guo C., et al. Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment. mBio. 2021;12:e00085-21. doi: 10.1128/mBio.00085-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00085-21</ArticleId><ArticleId IdType="pmc">PMC8092197</ArticleId><ArticleId IdType="pubmed">33906918</ArticleId></ArticleIdList></Reference><Reference><Citation>Siska P.J., Decking S.-M., Babl N., Matos C., Bruss C., Singer K., Klitzke J., Sch&#xf6;n M., Simeth J., K&#xf6;stler J., et al. Metabolic Imbalance of T Cells in COVID-19 Is Hallmarked by Basigin and Mitigated by Dexamethasone. J. Clin. Investig. 2021;131:e148225. doi: 10.1172/JCI148225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI148225</ArticleId><ArticleId IdType="pmc">PMC8592546</ArticleId><ArticleId IdType="pubmed">34779418</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold J.E., Okyay R.A., Licht W.E., Hurley D.J. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021;10:763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieniawska-&#x15a;miech K., Kuraszewicz A., Sado J., &#x15a;miech K., Lewandowicz-Uszy&#x144;ska A. Assessment of COVID-19 Incidence and the Ability to Synthesise Anti-SARS-CoV-2 Antibodies of Paediatric Patients with Primary Immunodeficiency. J. Clin. Med. 2021;10:5111. doi: 10.3390/jcm10215111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10215111</ArticleId><ArticleId IdType="pmc">PMC8584568</ArticleId><ArticleId IdType="pubmed">34768630</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrocchi E., Pighi C., Pascucci G.R., Cotugno N., Medri C., Amodio D., Colagrossi L., Ruggiero A., Manno E.C., Tumeo C.C., et al. Perinatally HIV-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 MRNA COVID-19 Vaccine Immunogenicity. Clin. Infect. Dis. 2022:ciac408. doi: 10.1093/cid/ciac408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac408</ArticleId><ArticleId IdType="pmc">PMC9278233</ArticleId><ArticleId IdType="pubmed">35738253</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID Following Mild SARS-CoV-2 Infection: Characteristic T Cell Alterations and Response to Antihistamines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Pittet L.F., Curtis N. How Common Is Long COVID in Children and Adolescents? Pediatric Infect. Dis. J. 2021;40:e482&#x2013;e487. doi: 10.1097/INF.0000000000003328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>